argenx
Biologics & Biosimilars · Rare Disease Therapeutics

argenx news and milestones

argenx: 7 headlines on record, 5 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 14, 2026 · Back to the company report
7Headlines
5In 90 days
2Milestones

Headlines

Sep 252026
News · Argenx stock last at EUR 842.40, up 0.91 percent in Euronext trading
Argenx stock was last at EUR 842.40 in Euronext Brussels trading at 5:12 p.m. CEST, up 0.91 percent from the previous close. The US-listed shares were at USD 958.15 in trading at…
Sep 212026
News · Argenx stock heads into the open after a strong September 18, 2026 gain
At the close on September 18, 2026, Argenx stock finished Nasdaq trading at 990.32 USD, marking a solid advance versus its prior level. The move came as investors digested growth…
Sep 182026
News · markets.businessinsider.com
September 17, 2026 - 22:01PM CETAmsterdam, the Netherlands - argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovation company, toda...
Sep 172026
Aug 272026
News · markets.businessinsider.com
Acquisition adds first-in-class anti-CD122 Antibody, FB102, to argenx's immunology pipelineAugust 27, 2026 - 8:50 AM ETAmsterdam, the Netherlands ...
Nov 28, 20252025
Sources: the outlets named on each headline, each story once

Milestones

2008
Founded
Each milestone is dated by its source: registers, filings, the press

How to cite

argenx, News. Alion, Nov 14, 2026. https://alion.io/company/argenx/news

.json · .md · CC BY-SA 4.0